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Wnt11 is a secreted protein that signals through the non-canonical planar cell polarity pathway and is a potent modulator of cell
behavior and movement. In human, mouse, and chicken, there is a single Wnt11 gene, but in zebrafish and Xenopus, there are two genes
related to Wnt11. The originally characterized Xenopus Wnt11 gene is expressed during early embryonic development and has a critical
role in regulation of gastrulation movements. We have identified a second Xenopus Wnt11-Related gene (Wnt11-R) that is expressed after
gastrulation. Sequence comparison suggests that Xenopus Wnt11-R, not Wnt11, is the ortholog of mammalian and chicken Wnt11.
Xenopus Wnt11-R is expressed in neural tissue, dorsal mesenchyme derived from the dermatome region of the somites, the brachial
arches, and the muscle layer of the heart, similar to the expression patterns reported for mouse and chicken Wnt11. Xenopus Wnt11-R
exhibits biological properties similar to those previously described for Xenopus Wnt11, in particular the ability to activate Jun-N-terminal
kinase (JNK) and to induce myocardial marker expression in ventral marginal zone (VMZ) explants. Morpholino inhibition experiments
demonstrate, however, that Wnt11-R is not required for cardiac differentiation, but functions in regulation of cardiac morphogenesis.
Embryos with reduced Wnt11-R activity exhibit aberrant cell–cell contacts within the myocardial wall and defects in fusion of the nascent
heart tube.
D 2005 Elsevier Inc. All rights reserved.
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During vertebrate development, splanchnic mesoderm
symmetrically located on either side of the midline is
specified to form cardiac tissue (DeRuiter et al., 1992;
Garcia-Martinez and Schoenwolf, 1993; Nascone and
Mercola, 1995; Sater and Jacobson, 1989; reviewed in
Schoenwolf and Garcia-Martinez, 1995). During subsequent
development, the paired cardiogenic tissues migrate ven-
trally until they fuse at the ventral midline of the embryo
(reviewed by Harvey, 1999, 2002; Mohun and Sparrow,
1997; Mohun et al., 2003; Zaffran and Frasch, 2002). The0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: pkrieg@email.arizona.edu (P.A. Krieg).heart primordia can be distinguished from the surrounding
mesoderm by expression of several cardiac transcription
factors including Nkx2-5, GATA4, and myocardin (Heikin-
heimo et al., 1994; Kelley et al., 1993; Lyons et al., 1995;
Wang et al., 2001). In the Xenopus embryo, the cardiac
progenitors begin to express sarcomeric differentiation
products, including cTnI, MLC-2, and MHCa, prior to
fusion of the heart patches (Drysdale et al., 1997; Raffin et
al., 2000; reviewed in Mohun et al., 2003). At the early
tailbud stage, the paired heart primordia fuse, first at the
ventral margin to form a U-shaped incomplete tube and later
at the dorsal surface to form a closed linear heart tube. After
tube formation, the heart undergoes a series of morphogenic
movements to form the final three-dimensional structure
consisting of the outflow tract and atrial and ventricular
chambers (Harvey, 2002; Mohun et al., 2000, 2003; Zaffran
and Frasch, 2002).279 (2005) 179–192
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known collectively as non-canonical Wnts, has been
demonstrated to play a role in modulating morphogenesis
and cell movements during development (reviewed in
McEwen and Peifer, 2000; Pandur et al., 2002a; Tada et
al., 2002). Wnt ligands bind to cysteine-rich frizzled and
ROR receptors and LRP5/6 coreceptors (Bhanot et al.,
1996; Hikasa et al., 2002; Wang et al., 1996; Wehrli et al.,
2000). After ligand binding, Wnt signaling is transduced
through several different pathways depending on the
particular Wnt protein involved. The canonical Wnt path-
way signals through dishevelled and results in the stabiliza-
tion of cytoplasmic h-catenin which then forms a
transcriptional complex with TCF/Lef family of HMG-box
transcription factors to activate expression of downstream
genes (van de Wetering et al., 1997). Alternatively, non-
canonical Wnt proteins activate a signaling pathway that
involves rho-GTPase, cdc42, and PKCy, and which results
in activation of Jun N-terminal kinase (JNK) (Kinoshita et
al., 2003; Marlow et al., 2002; Penzo-Mendez et al., 2003;
Yamanaka et al., 2002). It appears that non-canonical Wnts
can also signal through Rho kinase (Marlow et al., 2002)
and through alterations in intracellular Ca2+ levels to bring
about activation of PKC (Sheldahl et al., 1999), CAMKII,
and Calcineurin (Kuhl et al., 2000). One of the non-
canonical Wnt proteins, Wnt11, has been detected in the
developing myocardium of mouse and chicken embryos,
suggesting a role in some aspect of cardiac development
(Christiansen et al., 1995; Eisenberg et al., 1997).
Mis-expression of non-canonical Wnts can cause gross
malformations in embryonic development (Penzo-Mendez
et al., 2003; Ungar et al., 1995). These morphological
defects result from disruption of normal cell movements,
cell polarity, and cell adhesion rather than from alterations in
cell differentiation (Marlow et al., 2002; Moon et al., 1993;
Penzo-Mendez et al., 2003; Ungar et al., 1995). In Xenopus,
Wnt11 is expressed at high levels in the gastrulating embryo
(Ku and Melton, 1993) but, unlike chicken and mouse
(Christiansen et al., 1995; Eisenberg et al., 1997), is not
expressed in the developing heart. A recent report has
implicated Wnt11 activity in the pathway leading to cardiac
specification (Pandur et al., 2002a,b). In this study, high
doses of Wnt11 induced expression of cardiac markers such
as Nkx2.5 and MHCa and beating tissue was produced. The
heart inducing ability of Wnt11 requires the activation of
JNK and PKC but does not require CAMKII (Pandur et al.,
2002b). This inductive role for Wnt11 is very different from
the previously described role for Wnt11 in regulation of
gastrulation movements.
Here we present the characterization of Wnt11-R, a
second Wnt11 sequence in Xenopus, that is probably the
ortholog of chick and mammalian Wnt11. Xenopus Wnt11-
R is expressed in the differentiating heart myocardium in a
spatial and temporal expression consistent with a role in
heart tube morphogenesis. We show that Wnt11-R is not
required for cardiac specification or for expression ofmyocardial markers but is necessary for normal heart
morphogenesis.Materials and methods
Cloning of Xenopus laevis Wnt11-Related
Total RNA from stage 45 X. laevis hearts was oligo(dT)-
primed and reverse transcribed for use as a template for
PCR. Degenerate primers were used to amplify a 360 nt
region conserved in Wnt genes using standard conditions.
The forward primer (5V-CAA/GGA A/GTGT/C AAA/
GTGT/CCAT/CGG-3V, degenerate substitutions are under-
lined) was designed to the peptide sequence QECKCHG
and the reverse primer (5V-A/GCAA/GCACCAC/GTGA/
GAAT/CTTA/GCA-3V) was designed to the peptide
sequence CKFHWCC. Amplification products were cloned
and DNA sequences of representative inserts were deter-
mined to identify different Wnt sequences. Full-length
Wnt11-R clones were isolated from a X. laevis whole
embryo stage 42 library using the Wnt11-R PCR fragment
as probe. For expression studies, the Wnt11-R coding
sequence was inserted into the translation vector, pT7TS
(Cleaver et al., 1996).
Embryology and microinjection
X. laevis embryos were staged according to Nieuwkoop
and Faber (1994) and cultured in 0.2  MMR. Micro-
injections occurred in 4% Ficoll in 0.4  MMR and
embryos were maintained in this medium for the first 12 h.
Embryos were then cultured in 0.2  MMR until harvested.
For mis-expression experiments, Wnt11-R synthetic mRNA
was prepared from Wnt11-R/pT7TS plasmid linearized with
XbaI and transcribed with T7 RNA polymerase (Ambion).
For Western analysis, injected embryos were processed at
stage 12.5. For RT-PCR, VMZ and DMZ explants were
dissected from injected embryos at stage 10.5 and cultured
until stage 32 equivalent when they were processed.
Morpholino oligos were designed to sequences in the 5V
UTR of Wnt11-R common to both pseudotetraploid copies
of the gene. Wnt11-R MO1 (5V-AATCATCTTCAAACC-
CAATAACAA-3V), Wnt11-R MO2 (5V-AAACCCAATAA-
CAAATAAATTTA-3V), and control MO (5V-CTTGT-
ACTTCTATAGCCTATAAGAA-3V). MOs were stored in
50 mM HEPES, pH 8.0, diluted in water, and heated to
658C for 10 min prior to injection. The Wnt11-R MO tester
construction contains 350 bp of the 5VUTR and the first
three codons of Wnt11-R mRNA sequence fused to the
coding region of green fluorescent protein (Wnt11-R/GFP).
The tester construct was injected into the single-cell
Xenopus embryo at a dose of 500 pg or coinjected with
15 ng of MO. For heart targeting, 15 ng of MO was injected
at the 4 and 8 cell stage into the dorsal blastomeres in
medium containing 0.4  MMR and 4% Ficoll.
R.J. Garriock et al. / Developmental Biology 279 (2005) 179–192 181RT-PCR and Western analysis
RT-PCR primer pairs are as follows: cardiac Troponin I
(Vokes and Krieg, 2002) (Tm = 638C); MLC-2: forward: 5V-
GAGGCATTCAGCTGTATCGA-3V, reverse: 5’-GGACTC-
CAGAACATGTCATT-3V (Tm = 608C). Crude protein
extracts from embryos and explants were prepared by
homogenization and sonication in 2 SDS sample loading
buffer prior to fractionation using SDS–PAGE. Western
analysis and whole mount immunocytochemistry were
carried out using the following primary antibodies: phos-
pho-JNK (sc-6254, Santa Cruz Biotechnology), actin (A-
4700, Sigma), diphosphorylated ERK1/2 (M-8159, Sigma),
N-cadherin (610921, BD Biosciences).
Whole-mount in situ hybridization
Whole-mount in situ hybridization was carried out
using a modification of the protocol by Harland (1991)
with antisense digoxigenin-labeled probes to cardiac actin,
MHCa, MLC-2, and Wnt11-R. Plasmids were linearized
with Not1 and transcribed with T7 RNA polymerase using
the MEGAscript kit (Ambion). For serial sections,
embryos were post-fixed in 4% paraformaldehyde, embed-
ded in Paraplast, and 10 Am transverse sections were
prepared.Results
Isolation of a second Xenopus Wnt11 sequence, Wnt11-R
In mouse and chicken embryos, the Wnt11 gene is
expressed in the dorsal neural tube, dorsal dermamyotome,
neural crest cells, and in the developing heart (Christiansen
et al., 1995; Eisenberg et al., 1997; Kispert et al., 1996). In
contrast, the Xenopus and zebrafish Wnt11 genes are
expressed strongly in mesoderm tissue during gastrulation,
but are not expressed in the cardiogenic region in the later
stage embryo (Ku and Melton, 1993; Makita et al., 1998).
In a degenerate-primer PCR survey for Wnt sequences
expressed in the stage 45 X. laevis heart, we identified a
Wnt11-Related sequence distinct from the previously
described Xenopus Wnt11 gene. Full-length cDNA clones
corresponding to the variant Wnt11 sequence (which will
be referred to as Wnt11-R) were isolated from a stage 42
X. laevis embryo library and the nucleotide sequence was
determined. The Xenopus Wnt11-R coding region is 1056
nt long and encodes a 352 amino acid preprotein with a
calculated MW of 39.5 kDa. Alignment of the deduced
Xenopus Wnt11-R protein sequence with human, chicken,
zebrafish, and Xenopus Wnt11 proteins is presented in Fig.
1A. A matrix showing the percentage sequence identity
between the different Wnt11 proteins (excluding the highly
variable signal sequence) is shown in Fig. 1B, and we
have assembled a phylogenetic tree illustrating the possiblerelationships of the different Wnt11 sequences (Fig. 1C).
Xenopus Wnt11-R shows greater sequence identity to the
human and chicken Wnt11 proteins than to the previously
described Xenopus Wnt11 sequence. Xenopus Wnt11-R is
81% and 89% identical to human and chicken Wnt11
proteins, respectively, but only 64% identical to Xenopus
Wnt11. In contrast, Xenopus Wnt11 shows only 64% and
66% sequence identity to the human and chicken
sequences. We note also that, within the coding region,
the Xenopus Wnt11-R and Wnt11 sequences are only 63%
identical at the nucleotide level. This is much less than the
approximately 94% nucleotide sequence identity observed
for pseudoalleles in the X. laevis genome (Tonissen and
Krieg, 1993), and we therefore conclude that Wnt11 and
Wnt11-R represent two distinct genes. Based on sequence
relationships, we propose that Wnt11-R probably repre-
sents the Xenopus ortholog of the human and chicken
Wnt11 sequences. This argument is supported by the
embryonic expression pattern of Xenopus Wnt11-R illus-
trated below.
Embryonic expression of Wnt11-R
Expression of Wnt11-R during Xenopus development
was examined by in situ hybridization. Wnt11-R tran-
scripts were first detected in the late gastrula (st. 13) in
two symmetrical lines very close to the position of the
neural folds (Fig. 2A). At mid-neurula (st. 22), Wnt11-R
transcripts were detected along the dorsal axis in the
brain, neural tube, and the somites (Fig. 2B). Transverse
sections reveal that expression is confined to the extreme
dorsal region of the somite (Fig. 2C). Consistent with the
Wnt11 patterns in mouse and chicken, this region of
expression marks the dermatome primordia of the somite
and associated mesenchymal cells. At mid-neurula,
Wnt11-R transcripts were also observed in the dorsal
neural tube (Fig. 2C). At later neurula stages (st. 26),
expression of Wnt11-R is present in the dorsal mesen-
chyme extending from the otic vesicle to the tail, in the
branchial arch region, and in the nervous system (Figs.
2D and E). Wnt11-R transcripts were not detected in the
heart-forming region at stage 26 (Fig. 2F). At approx-
imately stage 28, however, when the first cardiac differ-
entiation markers are expressed, and immediately prior to
fusion of the heart tube, Wnt11-R expression was visible
in the heart primordia (Figs. 2G–J). In the tailbud embryo
(st. 35), Wnt11-R continues to be expressed in the
branchial arches, neural tube, somites, and the heart (Fig.
2K). Transverse sections at stage 35 showed Wnt11-R
expression in the dorsal neural tube and in the dorsal and
lateral boundaries of the somites (Fig. 2L). Expression
was also seen in mesenchymal cells that populate the
dorsal fin. Sections through the stage 34 heart indicated
that Wnt11-R was expressed in a subset of the
myocardium, in particular the anterior myocardium of
the heart tube comprising the outflow tract (Fig. 2M) and
Fig. 1. A second Xenopus Wnt11-Related gene, Wnt11-R, is closely related to mammalian Wnt11 genes. (A) Protein sequence alignment of
Xenopus Wnt11-R with Wnt11 and Wnt11-Related proteins from other species. Accession numbers are as follows: human Wnt11, AB070218;
chicken Wnt11, NM204784; mouse Wnt11, NM009519; Xenopus Wnt11, L23542; zebrafish Wnt11, AF067429; and zebrafish Wnt11-R, BC066498. (B)
Sequence identity of different Wnt11 and Wnt11-R proteins. (C) Phylogenetic relationships of Wnt11 and Wnt11-R proteins (excluding the variable signal
sequence) prepared using MacVector software. The length of the branches of the tree is proportional to the evolutionary distance measured by amino acid
changes per residue.
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the posterior heart tube representing the future atrial
myocardium (Fig. 2O). By the tadpole stage (st. 45),
Wnt11-R is expressed throughout the myocardium but
more strongly in the ventricular tissue (Fig. 2Q).Mis-expression of Wnt11-R activates JNK and induces
cardiac marker expression
We have carried out a series of experiments to determine
whether Wnt11-R shares biological activities with Wnt11.
Fig. 2. In situ hybridization analysis of Wnt11-R expression during Xenopus development. (A) Dorsal view of st. 13 embryo showing earliest Wnt11-R
expression in the dorsal region of the developing somites (arrow). (B) Dorsal view at st. 22 showing transcripts in the somite and neural tube. (C) Transverse
section at st. 22 shows that Wnt11-R transcripts are limited to the dorsal margin of the somite (arrow) and the dorsal neural tube. (D) Dorsal view at st. 26
showing Wnt11-R expression in the somites, branchial arches, neural tube, and brain. (E) Lateral view of st. 26 embryo. (F) Ventral view of st. 26 embryo. (G)
Lateral view at st. 28 shows Wnt11-R in the heart myocardium (arrow). (H) Lateral view at st. 28 with expression of MHCa marking the precardiac region. (I)
Ventral view of st. 28 embryo showing Wnt11-R expression in precardiac tissue. (J) Ventral view of st. 28 embryo stained for MHCa expression. (K) Lateral
view at st. 35 showing Wnt11-R expression in the branchial arches, somites, neural tube, fin, and the heart. (L) Transverse section through the a medial region
of a st. 35 embryo showing Wnt11-R transcripts in the dorsal margin of the somite, dorsal neural tube, and mesenchymal cells within the fin. (M–O) Transverse
sections progressing from anterior to posterior regions through the heart tube of a st. 35 embryo showing Wnt11-R expression in the myocardium of the heart.
Sections show the future outflow tract and ventricle (M), the ventricle (N), and the atria (O). (P) MHCa expression in section equivalent to that in O, showing
expression throughout myocardial layer. (Q) Wnt11-R is expressed throughout the myocardium of the st. 45 heart, although expression is lower in atrial tissues.
Atria and ventricular (vent) tissues are indicated. (R) MHCa expression in the st. 45 heart showing strong expression throughout the myocardium.
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when mis-expressed in the Xenopus embryo. Previous
studies have shown that Wnt proteins signaling through the
beta-catenin pathway generate secondary axes with high
frequency when expressed in ventral blastomeres (Pandur et
al., 2002a). For example, we were able to demonstrate that
expression of the canonical Wnt8a sequence was highlyefficient at producing duplicated axes (Fig. 3B). However,
secondary axes were not produced by similar doses of
Wnt11-R (Fig. 3C). Second, previous studies have shown
that ectopic expression of Wnt11 in the Xenopus embryo
causes severe disruption of normal gastrulation movements
(Penzo-Mendez et al., 2003; Tada and Smith, 2000) and we
have confirmed this result for Wnt11-R. As shown in Table 1,
Fig. 3. Activity of Wnt11-R in whole embryo injections and cultured ventral marginal zone explants. (A) Dorsal view of uninjected stage 22 control embryo.
(B) Sibling embryos injected with 50 pg of Wnt8a mRNA into a ventral blastomere at the 8 cell stage exhibit axis duplications. (C) Sibling embryos injected
with 50 pg of Wnt11-R mRNA at the 8-cell stage do not show axis duplications. (D) Dorsal view of a stage 22 embryo injected with 500 pg of GFP at the one
cell stage. (E) Sibling embryo injected with 100 pg of Wnt11-R at the one cell stage exhibiting gross abnormalities in embryonic development due to
gastrulation defects. (F) Protein blots of extracts derived from stage 12.5 VMZ explants injected with 500 pg of GFP mRNA or a dose range of Wnt11-R
mRNA from 100 pg to 1 ng. Immunoblots show the presence of activated JNK (p-JNK) and activated ERK 1/2 (p-ERK). Actin was used as loading control.
(G) Protein blots of extracts from stage 12.5 VMZ explants. Embryos were injected with 1 ng of Wnt11-R mRNA and cultured in the absence or presence of 10
AM SP600125 JNK inhibitor for 5 h, as indicated. Immunoblots detect the presence of p-JNK and actin. (H) RT-PCR analysis of VMZ explants expressing
Wnt11-R at the equivalent of stage 32. Amplification products corresponding to the myocardial specific transcripts, myosin light chain-2 (MLC-2) and cardiac
troponin I (cTnI), are indicated. Elongation factor-1a (EF1a) is a ubiquitous transcript that serves as a loading control. RNA extracts from dorsal marginal zone
explant tissue (DMZ), which contain the endogenous heart, and whole embryo (st. 32), were used as positive controls. Doses of injected Wnt11-R mRNA in
VMZ explants are indicated.
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stage embryos resulted in defective gastrulation at doses from
100 pg to 1 ng. Even at 100 pg, allWnt11-R-injected embryos
showed gastrulation defects including incomplete closure of
the blastopore and neural tube (Fig. 3E). These defects were
not observed in control embryosmicroinjected with 500 pg of
GFP mRNA (Fig. 3D).
Third, we assayed whether Wnt11-R could activate JNK
and induce cardiac marker expression, as previously
demonstrated for Wnt11 (Pandur et al., 2002b). Embryos
were injected with different amounts of synthetic Wnt11-R
mRNA at the one cell stage and then protein extracts from
explants of gastrula stage embryos (st. 12.5) were assayed
for JNK activation by Western blot using a phospho-JNK
specific antibody (Fig. 3F). This assay showed a dose-Table 1
Embryonic over-expression of Wnt11-R causes morphological defects
Injected mRNA Morphological defects
(assayed a stage 22)
1 ng EGFP 2% (n = 56)
100 pg Wnt11-R 96% (n = 75)
250 pg Wnt11-R 100% (n = 36)
500 pg Wnt11-R 98% (n = 58)
1 ng Wnt11-R 100% (n = 89)dependent increase in JNK activation with increasing levels
of Wnt11-R. The treatment did not result in an increase in
levels of diphosphorylated ERK1/2, which is not activated
by Wnt11 signaling (Fig. 3F). The Wnt11-R induced
activation of JNK in VMZ explants could be blocked by
the JNK inhibitor SP600125 (Fig. 3G). RNA extracts from
VMZ explants of Wnt11-R injected embryos (st. 32
equivalent) were tested for the presence of cardiac marker
transcripts using RT-PCR (Fig. 3H). Two myocardial
specific markers MLC-2 and cTnI were detected in VMZ
explants from embryos injected with high levels (1 ng) of
Wnt11-R mRNA but not at the lower doses that were
sufficient to disrupt gastrulation movements. Overall, these
experiments indicate that Wnt11-R signals through the non-
canonical Wnt pathway and exhibits biological activities
equivalent to Wnt11.
Inhibition of Wnt11-R function using morpholino oligomers
does not alter myocardial marker expression
To investigate a possible role for Wnt11-R in heart
development, we utilized a morpholino (MO) antisense
strategy to translationally inhibit the expression of Wnt11-R.
Two morpholinos, MO1 and MO2, were designed, each
corresponding to regions showing 100% sequence identity
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genes. The ability of these MOs to inhibit translation of
Wnt11-R mRNA in the embryo was tested using a synthetic
mRNA consisting of the 5’ UTR and first 3 codons of
Wnt11-R fused to the coding region of EGFP (Fig. 4A).
Injection of 500 pg of this synthetic mRNA into Xenopus
embryos produced bright fluorescence due to translation of
EGFP protein (Fig. 4B). Coinjection of the tester mRNA
with 15 ng of either MO1 or MO2 showed that only the MO
overlapping the initiation codon (MO1) was able to inhibit
translation of EGFP and block fluorescence (Fig. 4D). MO2
produced no detectable reduction in fluorescence (data not
shown). This assay appears to be a useful test for inhibitor
activity, since subsequent experiments showed that MO2
had no detectable effect on Wnt11-R function in the embryo
(data not shown). The inhibition of EGFP translation by
MO1 was confirmed by protein blotting using antibodies
directed against GFP (Fig. 4E). As expected, a control MO
containing 11 base changes relative to MO1 had no
detectable effect on EGFP expression (data not shown).
To determine the developmental consequences of inhib-
ition of Wnt11-R expression in the heart, 15 ng of MO1 wasFig. 4. Wnt11-R antisense morpholino oligomer inhibits translation from Wnt11-R
mRNA, indicating binding locations for antisense MO1 and MO2. The ability of M
assayed by coinjecting 500 pg of synthetic tester mRNA with 15 ng of Wnt11-R
under UV light or standard illumination. Uninjected embryos (B) serve as negative
confirming the translation of GFP protein. Embryos coinjected with MO1 plus t
inhibition of translation. The second Wnt11-R antisense MO, MO2, showed no inh
detection of GFP protein in whole embryo extracts from uninjected embryos, teste
15 ng of MO1. GFP protein is detected in the tester sample, but is not detectable
loading of sample. (F) Embryo injected with 15 ng of control MO (contMO) ass
differentiation. (G) Embryo injected with 15 ng of MO1 also shows normal appeinjected into one or both of the D2 blastomeres of the 8-cell
embryo. Fate mapping shows that these cells contribute to
heart and somitic tissues (Dale and Slack, 1987; Moody,
1987). The uninjected side of the embryo serves as a stage
matched control. In initial experiments, MO1-injected
embryos were allowed to develop until early tailbud (st.
28) when they were assayed for expression of cardiac
differentiation markers. As shown in Fig. 4G, inhibition of
Wnt11-R expression had no detectable effect on expression
of MHCa, which is an early and very strong marker of
myocardial differentiation (Logan and Mohun, 1993).
Similarly, expression of the cardiac marker MLC-2 was
normal in MO1-injected embryos (Table 2) and no effects
on cardiac gene expression were observed when embryos
were cultured until the tailbud stage (Table 2). Assays with
specific cardiac probes cannot exclude the possibility that
Wnt11-R is important for regulation of an unspecified gene
that is essential for normal myocardial differentiation. To
test for consequences later in development, MO1 was
injected bilaterally and embryos were allowed to develop
until the tadpole stage (st. 45). In 100% of cases, double-
side-injected embryos had beating hearts (Table 2), indicat--GFP fusion transcripts. (A) Diagram of the Wnt11-R/GFP fusion (tester)
Os to inhibit translation from mRNAs containing Wnt11-R sequences was
MO1 into fertilized eggs. (B–D) At about stage 13, embryos were viewed
control and do not glow. Embryos injected with tester mRNA (C) fluoresce,
ester mRNA (D) show strongly reduced fluorescence, indicating effective
ibition of GFP expression using this assay (data not shown). (E) Immunoblot
r mRNA-injected embryos, and embryos coinjected with tester mRNA and
when translation is inhibited by MO1. Ponceau S staining indicates equal
ayed at st. 28 by in situ hybridization for MHCa, showing normal cardiac
arance of differentiation markers when assayed for MHCa transcripts.
Table 2
Expression of cardiac differentiation markers and cardiac beating is normal in Wnt11-R MO-treated embryos
Treatment Heart patch symmetry (assayed at stage 28) MHCa expression Beating hearts
MHCa MLC-2 (assayed at stage 35) (stage 45)
Uninjected 97% (31) 93% (31) 100% (34) 100% (39)
Control MO 97% (35) 96% (24) 100% (83) 100% (17)
Wnt11-R MO1 92% (39) 93% (28) 100% (70) 100% (87)
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expressed in Wnt11-R-depleted embryos.
Inhibition of Wnt11-R function using morpholino oligomers
causes defects in heart morphogenesis
We examined the heart region of Wnt11-R-depleted
embryos to detect possible alterations in cell behavior or cell
movement. During early tailbud stages, double-sided MO1-
injected embryos formed normal patches of precardiac
tissue that migrated to the ventral midline (Figs. 5A–D).
The first alterations in cardiac morphology became evident
during the process of heart tube formation (Figs. 5E–K). At
stage 34, transverse sections through MO-treated embryos
showed that, although the cardiac primordia migrated
normally and came to abut at the ventral midline, the heart
primordia did not fuse properly. This resulted in a subset of
myocardial cells protruding into the endocardial space at the
midline (Figs. 5J and K). We also observed a delay in
closing of the tube in the dorsal region (Figs. 5J and K),
although this defect corrected itself during subsequent
development (data not shown). These alterations in mor-
phology were highly reproducible and were observed in
58% of Wnt11-R MO1-treated embryos (25 of 43 embryos
sectioned from three independent experiments) but almost
never in control embryos (3%, 1 in 33). Based on
inspection of external morphology, hearts of MO-treated
embryos cultured until tadpole stages (stage 45) appeared
to have largely recovered normal morphology, although
approximately 10% the hearts (5/49) exhibited a pro-
nounced cardia bifida phenotype (Figs. 5M and N). These
hearts showed duplications of the outflow tracts, ventricle
and atria, probably resulting from a failure of correct tube
fusion. This phenotype was never observed in control
embryos (0/56).
A second major alteration in cardiac morphology also
became visible at the time of fusion of the heart primordia.
When embryos injected with Wnt11-R MO on one side only
were examined in section, it was clear that the myocardial
layer on the injected side was thicker than on the control
side (Figs. 5O and P). This is also visible in double-sided
MO1-injected embryos (compare Figs. 5G and J). Quanti-
tation of differentiated myocardium (marked by MHCa
expression) showed that the area of the Wnt11-R-depleted
side was 26% larger than the control side. Possible causes
for the expanded myocardial layer are examined in more
detail below.Wnt11-R/JNK signaling during cardiac morphogenesis
Non-canonical Wnt signaling is mediated, in part,
through activation of the JNK pathway (reviewed in Pandur
et al., 2002a; Tada et al., 2002), and we have demonstrated
that Wnt11-R is capable of JNK activation in embryonic
tissue (Fig. 3F). Phosphorylation of JNK in the cytoplasm
results in translocation of JNK protein to the nucleus
(Reviewed in Weston and Davis, 2002). Whole mount
immunostaining shows that the phospho-JNK protein was
broadly distributed in the early tailbud embryo, including
the precardiac region (Fig. 6A). To determine if activated
JNK is present in the myocardium, we examined early heart
tube stage embryos (st. 30) for nuclear localized JNK
staining. Phosphorylated JNK could be detected using the
anti-phospho-JNK antibody, SC-6254, within the myocar-
dial tissue layer in sectioned embryos (Figs. 6B and C).
Staining was diffuse, but concentrated in the nucleus and
perinuclear region of the myocardial cells, as marked by
propidium iodide staining (Fig. 6D).
The presence of activated JNK in the myocardium is
consistent with a role for JNK in mediating Wnt11-R
signaling during heart tube formation. We therefore tested
whether inhibition of JNK activation, using the chemical
inhibitor SP600125, would replicate the cardiac pheno-
types of Wnt11-R MO treatment. Incubation of Xenopus
embryos with 20 AM SP600125, starting at stage 26
(approximately 2 h prior to the onset of Wnt11-R
transcription in the heart) until stage 33, had no effect
on embryo morphology, and myocardial marker expression
occurred at the normal time (Figs. 6E and G). Transverse
sections through treated embryos, however, revealed
abnormalities in heart morphology that were apparently
identical to those in Wnt11-R morpholino-treated embryos.
The hearts of SP600125-treated embryos exhibited defects
in heart tube fusion at the ventral midline and also an
increase in myocardial area (Fig. 6H). Quantitation showed
that the myocardial area was increased 19% relative to
controls. Another regulatory protein known to be involved
in transduction of Wnt signaling pathways is Ca(2+)/
calmodulin-dependent protein kinase II, CaMKII (Kuhl et
al., 2000), and previous studies have utilized the CaMKII
inhibitor KN-93 in Xenopus embryos (Pandur et al.,
2002b; Wu and Cline, 1998). When we treated embryos
with 20 AM KN-93, under identical conditions to those
used for SP600125, we observed no defects in normal
heart tube fusion, and no significant alteration in myo-
Fig. 5. Characterization of myocardial defects observed in Wnt11-R-depleted embryos. In all cases, myocardial tissue is detected by in situ hybridization using
MHCa probe. (A–D) One-sided injection of either contMO (A and B) or Wnt11-R MO1 (C and D) does not interfere with myocardial differentiation when
assayed at st. 28. (E–F) Control MO-injected embryos assayed at st. 34 showing normal expression of MHCa when viewed laterally (E), ventrally (F), or in
section G. (H–K) MO1-injected embryos assayed at st. 34 showing myocardial marker expression in lateral (H) and ventral (I) views. Sectioning of embryos
through the heart region (J and K) shows abnormal morphology of the heart tube. (L–N) Isolated hearts assayed at st. 45. Normal heart morphology is
illustrated in L and abnormal, partially bilaterally duplicated hearts from Wnt11-R-depleted embryos are shown in M and N. Atria (a), ventricle (v), and outflow
tracts (oft) are indicated. (O) Section through the heart tube of a st. 34 embryo injected with MO1 on one side, as indicated. (P) Same section as O showing
detection of cell nuclei using propidium iodide staining under UV light. The myocardial layer is outlined. Nuclei were counted to assay cell number in Wnt11-
R-depleted and -untreated myocardial tissue.
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results suggest that the JNK pathway, but not the CaMKII
pathway, is involved in transduction of Wnt11-R signaling
in the developing heart.
Three different mechanisms might account for the
increase in myocardial area observed in Wnt11-R morpho-
lino and JNK inhibitor-treated embryos; increased numbers
of cells, increased size of cells, or increased space between
the cells. A combination of more than one mechanism couldalso be at work. We determined the number of cells in the
myocardial wall of double-sided MO1-treated embryos and
stage-matched untreated control embryos. Quantitation of
cell nuclei number using DAPI visualization (Fig. 5P)
showed no statistical difference in cell number in the MO
treated and control myocardia (Table 3). Similarly, no
significant difference was observed when cell numbers were
determined for the myocardial layer of SP600125-treated
embryos (Table 3).
Fig. 6. Characterization of myocardial defects in Wnt11-R-depleted and JNK-inhibited embryos. (A) Whole mount immunostaining of unmanipulated st. 30
embryo showing activated JNK (p-JNK) in the heart region (arrow). (B) Transverse section through heart region of st. 30 embryo showing p-JNK-positive cells
in the myocardial layer. (C) Transverse section through heart region of p-JNK-stained embryo. Arrowheads indicate regions of positive staining. (D) Nuclear
staining with propidium iodide of same section shown in C illustrating the p-JNK localization is perinuclear. (E–H) Comparison of media control and JNK
inhibitor (SP600125)-treated embryos at st. 33. (E and G) Whole mount in situ hybridization shows normal initiation of MHCa expression in treated and
untreated embryos. (F and G) Transverse sections through the heart region of MHCa-stained embryos show that inhibition of JNK activation produces
morphological defects in heart tube formation. (I–L) Transmission electron micrographs of transverse plastic sections through the myocardial wall from
unmanipulated control and treated embryos at st. 33. In all panels, the endocardial side of the tube is to the right. Prominent dark spots are yolk granules. In all
cases, spaces between adjacent cells have been colored in yellow. (I) Untreated control heart shows tightly packed columnar cells in myocardial wall with little
space between adjacent cells. (J) Wnt11-R MO1-treated embryos show thickened wall of myocardium and increased extracellular space. (K) DMSO media-
treated control hearts show very little space between adjacent cells in myocardium. (L) JNK inhibitor (SP600125)-treated embryos show increased thickness of
myocardial layer and more extracellular space relative to DMSO-treated controls.
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to take a closer look at myocardial cells. Sections through a
control heart at stage 34 showed that the myocardium
consisted of a single layer of columnar cells (Fig. 6I). In
most cases, the nuclei were located closer to the outer
surface of the heart tube. Each myocardial cell was closely
juxtaposed to its neighbors with little extracellular space
visible at the margin between cells. Measurements from the
TEM images showed that the average area of a myocardial
cell in Wnt11-R morpholino and JNK inhibitor-treatedTable 3
Increased myocardial area in Wnt11-R MO-treated and JNK inhibitor-treated em
Morpholino treatment No. of nuclei in myocardium
(assayed stage 34)
Control MO 59.4 F 4.8 (8)
Wnt11-R MO1 59.1 F 9.3 (7)
Inhibitor treatment No. of nuclei in myocardium
(assayed stage 32)
DMSO (carrier) 43.1 F 4.6 (8)
DMSO + SP600125
(20 Ag/ml)
43.0 F 6.7 (11)embryos (Figs. 6J and L) was not significantly different
from that of sibling control embryos (Table 3). However,
Wnt11-R MO and JNK inhibitor-treated embryos showed an
increase in the extracellular space between neighboring cells
(marked in yellow in Figs. 6I–L) possibly due to decreased
adhesion between cells. Quantitation indicated that the
proportion of the total myocardial area represented by open
extracellular space was 4-fold greater in MO-treated
embryos than in controls (16% vs. 4%, respectively).






78.1 F 12.4 (8) 0.76





63.1 F 10.5 (8) 0.68
75.0 F 14.3 (11) 0.57 0.026
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suggest that the observed increase in extracellular space in
MO-treated or inhibitor-treated embryos relative to controls
is a major factor contributing to increase in the area of the
myocardial tissue layer. However, extracellular space alone
is not sufficient to account for the entire difference in area
(approximately 25% greater than controls), suggesting that
other factors, not readily detectable using TEM, must also
contribute to the knockdown phenotype. One possibility is
that the reduced adhesion leads to slippage of cells out of a
strictly columnar arrangement, leading to increased width of
the myocardial layer.Discussion
Vertebrate Wnt11 and Wnt11-Related genes
During development of Xenopus and zebrafish, a Wnt11
gene is expressed in the involuting mesoderm of the gastrula
stage embryo (Ku and Melton, 1993; Makita et al., 1998).
Later during development, this gene is expressed in the
branchial arch region and the somite, but not in the heart.
Dominant-negative inhibition studies in Xenopus and
mutant analysis in zebrafish indicate that this Wnt11 gene
plays an important role in regulation of gastrulation move-
ments (Heisenberg et al., 2000; Tada and Smith, 2000;
Ulrich et al., 2003). In contrast, the Wnt11 genes identified
in chicken and mouse are not expressed in the gastrulating
mesoderm (Christiansen et al., 1995; Eisenberg et al., 1997;
Kispert et al., 1996). Transcripts of the chicken and mouse
Wnt11 genes are observed in the branchial arch region, the
dermamyotome and adjacent dorsal mesenchyme of the
somites, and in the developing heart. We have identified
Wnt11-R, a second Xenopus Wnt11 gene that, based on
sequence comparison and embryonic expression pattern, is
likely to represent the ortholog of the single Wnt11 gene
reported in chicken and mouse. A second Wnt11-Related
sequence is also present in zebrafish (accession number
AAH66498 and Fig. 1A), and while no expression
information for this gene is currently available, we predict
that it will exhibit a pattern similar to that of Wnt11-R. It
seems likely that the multiple Wnt11 genes in fish and frogs
resulted from an ancient gene duplication event, but that the
second copy has been lost in birds and mammals.
Experiments using Xenopus embryos show that either
mis-expression or inhibition of Wnt11 activity causes severe
alterations in cell movements resulting in defective gastru-
lation (Marlow et al., 2002; Penzo-Mendez et al., 2003). In
addition, high level expression ofWnt11 can cause activation
of JNK and induce expression of cardiac differentiation
markers in embryonic explants (Pandur et al., 2002a,b).
Since Xenopus Wnt11 and Wnt11-R are clearly closely
related sequences, we have carried out tests for biological
activity and demonstrated that mis-expression of Wnt11-R
also causes severe gastrulation defects (Fig. 3E) and leads toactivation of JNK and induction of heart markers (Figs. 3F
and H). We therefore conclude that Wnt11 and Wnt11-R
share at least some of the same biological activities.
Wnt11-R is required for heart tube morphogenesis
In Drosophila, the planar cell polarity pathway (PCP)
plays an essential role in the regulation of embryonic
morphogenesis (reviewed in Fanto and McNeill, 2004). In
vertebrates, the PCP pathway is stimulated by non-canonical
Wnt ligands, particularly Wnt5A and Wnt11, and also
functions to regulate cell behavior and movement (Tada et
al., 2002; Wallingford et al., 2002). To assess whether
Wnt11-R is involved in regulation of cell movement and
adhesion during heart development, we downregulated
Wnt11-R activity using a MO approach. First, we observed
that inhibition of Wnt11-R function has no discernible effect
on the timing or pattern of expression of myocardial marker
genes. This is completely consistent with expectations, since
Wnt11-R is not normally expressed in heart tissue until the
time that cardiac markers are expressed (Figs. 2G–J).
Second, we showed that although the initial stages of
migration of the cardiac primordia to the ventral midline
progressed normally, fusion of the primordia to form the
primitive heart tube was disrupted. The most common
defect, observed in almost 60% of cases, was a thickening of
the myocardial wall and an accumulation of disorganized
cells at the site where fusion would normally occur (Fig. 5J).
In the most extreme cases, the individual heart primordia
form two adjacent U-shaped tubes (Fig. 5K) and a small
proportion of hearts (about 10%) went on to exhibit partial
cardia bifida (Figs. 5M and N). The thickened myocardial
wall that was evident in heart tube stage embryos was
undetectable in later stage hearts (data not shown). This loss
of phenotype could be due to degradation of the morpholino
inhibitor and restoration of Wnt11-R protein levels or,
alternatively, another non-canonical Wnt protein may
become expressed in the heart and substitute for Wnt11-R
activity. Interestingly, defective cardiac morphology is also
observed in the Loop-tail mouse mutant (Lpp1) (Henderson
et al., 2001; Murdoch et al., 2001). Lpp1 is related to
Drosophila Strabismus, a factor in the PCP signaling
pathway (reviewed in Heisenberg and Tada, 2002).
Although the precise cause of the morphological flaws in
Lpp1 mutant hearts is not clear, it is tempting to speculate
that both Lpp1 and Wnt11-R defects are due disruption of
the PCP pathway within the myocardium.
Wnt11 signaling through JNK functions to regulate
embryonic morphogenesis, particularly in the context of
convergent extension movements during gastrulation
(Yamanaka et al., 2002). However, apart from gastrulation,
there are no other examples of JNK-dependent morpho-
genesis. The experimental results presented in this paper
provide three lines of evidence suggesting a role for JNK-
mediated Wnt11-R signaling in regulation of cardiac
morphogenesis. First, expression of Wnt11-R in Xenopus
R.J. Garriock et al. / Developmental Biology 279 (2005) 179–192190embryonic tissue can induce JNK phosphorylation (Fig. 3F).
Second, Wnt11-R is expressed in the heart at the time that
activated JNK is present (Figs. 6C–E), consistent with a role
for Wnt11-R in activation of JNK. Third, depletion of
Wnt11-R by MO treatment generates phenotypes indistin-
guishable from those obtained by inhibiting JNK activation
(Figs. 5J and 6H). We interpret these results to suggest that
Wnt11-R is signaling through a currently unidentified Wnt
receptor to activate JNK and regulate subsequent myocardial
tissue movements. It is interesting to note that the myocardial
cell layer, which is expressing Wnt11, is also the cell layer
affected by Wnt11 depletion. This observation suggests that
Wnt signaling is acting cell autonomously to regulate cardiac
morphology, as previously proposed for regulation of
gastrulation movements (Tada and Smith, 2000).
To explore possible mechanisms underlying the defects
in cardiac development, we used electron microscopy to
examine the structure of the myocardial wall in Wnt11-R
MO and JNK inhibitor-treated embryos. Both of these
treatments cause the area of myocardial tissue to be
increased relative to control embryos without any detectable
increase in cell number (Table 3). Our TEM studies revealed
a reduction of close contact between individual cardiac cells
in treated embryos, associated with a significant increase in
extracellular space (approximately 4-fold over controls).
These observations might be explained by reduced cell
adhesion between individual cardiomyocytes comprising
the wall of the heart tube. It is possible that reduced
adhesion between myocardial cells allows them to slip out
of the regular columnar arrangement, leading to an increase
in the overall thickness of the myocardial wall (Figs. 6K and
M). A role for Wnt11-R in regulating cell adhesion and cell
contact is consistent with previous studies of the
mouseWnt5A gene. Knockout of Wnt5A results in ven-
tricular septal defects (Oishi et al., 2003; Yamaguchi et al.,
1999) and studies using cardiomyocytes in culture showed
that increased expression of Wnt5A enhanced stability of N-
cadherin protein at sites of adhesion without influencing
transcription of the N-cadherin gene (Toyofuku et al., 2000).
N-cadherin does not appear to underlie the effects observed
in Wnt11-R-deficient Xenopus embryos, however, since we
were unable to detect any alteration in N-cadherin protein
levels relative to controls (data not shown).
Does Wnt11 function as a cardiac inducer?
The blastopore lip region of the frog embryo, where
Wnt11 is expressed, is also the region involved in induction
of the cardiac lineage (Nascone andMercola, 1995; Sater and
Jacobson, 1989). Similarly, in the chick embryo, Wnt11 is
reported to be expressed in the cardiac crescent (Eisenberg et
al., 1997), although subsequent studies of chick have failed
to detect Wnt11 expression in the cardiogenic region
(Chapman et al., 2004). Based initially on these observations
of Wnt11 expression in precardiac tissues, it has been
proposed that Wnt11 plays a central role in the specificationof the heart lineage (Pandur et al., 2002b), and over-
expression experiments using Xenopus tissue explants
showed that Wnt11 can induce expression of cardiac
markers. We have confirmed these results by showing that
over-expression of Wnt11-R also induces expression of
cardiac genes (Fig. 3H). We note, however, that Wnt11-R is
not expressed in cardiac tissues until about the time of
myocardial differentiation (Fig. 2) and therefore cannot
normally play a role in induction of the cardiac lineage. In the
frog embryo, expression of dominant-negative Wnt11 dis-
rupts normal gastrulation movements (Tada and Smith,
2000) and zebrafish silberblick (Wnt11) mutants show
defects in gastrulation (Heisenberg et al., 2000; Ulrich et
al., 2003). Significantly, no cardiac defects are apparent in
silberblick mutants (Heisenberg and Nusslein-Volhard,
1997), indicating that Wnt11 is not essential for specification
of the cardiac lineage in zebrafish.
Taking the available information into account, we wish to
suggest that induction of cardiac markers by high levels of
Wnt11 and Wnt11-R may be an artifact of the over-
expression assay. This proposal is based on the observation
that high level expression of Wnt proteins normally involved
in non-canonical signaling can inhibit the canonical Wnt
signaling pathway (Topol et al., 2003; Weidinger and Moon,
2003; Yan et al., 2001). Indeed, this has been demonstrated
specifically for Wnt11 (Maye et al., 2004). Previous studies
in avian and frog embryos have shown that disruption of
canonical Wnt signaling, using the inhibitory proteins
dickkopf or crescent, results in activation of the cardiac
differentiation pathway and ectopic expression of myocar-
dial markers (Marvin et al., 2001; Schneider and Mercola,
2001). We suggest that high level expression of either Wnt11
or Wnt11-R in ventral marginal zone explants is approx-
imately equivalent to expression of the Wnt inhibitors dkk or
crescent and is sufficient to inhibit canonical Wnt signaling
and to activate heart marker expression.
The results presented in this report suggest that Wnt11-R
functions to control cell behavior during morphological
movements. In particular, evidence has been presented
showing that the disruption of cardiac morphology observed
in Wnt11-R-deficient embryos is associated with changes in
adhesion properties of cells in the myocardial wall. At its
most extreme, these alterations in cell behavior generate a
cardia bifida phenotype (Figs. 5M and N). At present,
however, it is not known which genes are regulated in
response to Wnt11-R signaling or which specific proteins
mediate Wnt11-R-regulated cell adhesion. Loss of function
studies for the single Wnt11 gene in the mouse genome
should help to resolve the role of Wnt11 during cardiac
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